Bronchial Hyperresponsiveness Changes After 5 Months of Regular Procaterol Inhalation Therapy in Asthmatic Children

References

• Nadel J A. Inflammation and asthma. J Allergy Clin Immunol 1984; 73: 651
   PubMed Web of Science ®Google Scholar
• Magnussen H, Nowak D. Roles of hyperresponsiveness and airway inflammation in bronchial asthma. Respiration 1989; 55: 65
   PubMed Web of Science ®Google Scholar
• Cockcroft D W, Killian D N, Mellon J JA, Hargreave F D. Bronchial reactivity to inhaled histamine: a method and clinical. Clin Allergy 1977; 7: 235
   PubMedGoogle Scholar
• Eiser N M, Kerrebijn K F, Quanjer P H. Guidelines for standardization of bronchial challenges with (non-specific) bronchoconstricting agents. Bull Eur Physiopath Resp 1983; 19: 495
   PubMedGoogle Scholar
• Chhabra S K, Gaur S N, Khanna A K. Clinical significance of nonspecific bronchial hyperresponsiveness in asthma. Chest 1989; 96: 596
   PubMed Web of Science ®Google Scholar
• Mitchell E A. Is current treatment increasing asthma mortality and morbidity?. Thorax 1989; 44: 81
   PubMed Web of Science ®Google Scholar
• Tattersfield A E. Tolerance to beta-agonists. Bull Eur Physiopathol Respir 1985; 21: 1
   Google Scholar
• Harvey J E, Tattersfield A E. Airway response to salbutamol: effect of regular salbutamol inhalation in normal, atopic, and asthmatic subjects. Thorax 1982; 37: 280
   PubMed Web of Science ®Google Scholar
• Svedmyr N LV, Larsson S A, Thiringer G K. Development of resistance in beta-adrenergic receptors of asthmatic patients. Chest 1976; 69: 479
   PubMed Web of Science ®Google Scholar
• Conolly M E, Tashkin D P, Hui K KP, Littner M R, Wolfe R N. Selective subsensitization of betaadrenergic receptor in central airways of asthmatics and normal subjects during long-term therapy with inhaled salbutamol. J Allergy Clin Immunol 1982; 70: 423
   PubMed Web of Science ®Google Scholar
• Peel E T, Gibson G J. Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine. Am Rev Respir Dis 1980; 121: 973
   PubMed Web of Science ®Google Scholar
• Vathenen A S, Knox A J, Higgins B G, Britton J R, Tattersfield A E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988; 1: 554
   PubMed Web of Science ®Google Scholar
• Van Schayck C P, Graafsma S J, Visch M B, Dompeling E, van Weel C, van Herwaarden C LA. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol 1990; 86: 793
   PubMed Web of Science ®Google Scholar
• Ryan G, Latimer K M, Juniper E F, Roberts R S, Hargreave F E. Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma. J Allergy Clin Immunol 1985; 75: 25
   PubMed Web of Science ®Google Scholar
• Kraan J, Koeter G H, Mark T W, Sluiter H J, Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628
   PubMed Web of Science ®Google Scholar
• Kerrebijn K F, von Essen-Zandvliet E EM, Neijens H J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79: 653
   PubMed Web of Science ®Google Scholar
• Koda A, Yamada T, Nakagiri N. Anti-allergic actions of procaterol, a new β2-adrenergic drug. Jpn J Allergol 1979; 28: 417
   Google Scholar
• Tanaka M, Tomioka H, Yoshida S, Kumagai A. Inhibition of histamine release from human leukocytes by procaterol (OPC-2009), a new β2-adrenoceptor stimulant. Clinical Report, 13
   Google Scholar
• Ohuchi K, Hirasawa N, Takeda H, Asano K, Watanabe M, Tsurufuji S. Mechanism of antianaphylactic action of β-agonists in allergic inflammation of air pouch type in rats. Int Arch Allergy Appl Immun 1987; 82: 26
   PubMedGoogle Scholar
• Ohuchi K, Watanabe M, Hirasawa N, Yoshizaki S, Mue S, Tsurufuji S. Suppression by adrenoceptor beta-agonists of vascular permeability increase and edema formation induced by arachidonate metabolites, platelet-activating factor, and tumor promoting phorbol ester TPA. Immunopharmacology 1990; 20: 91
   Google Scholar
• Kawamura K, Hara T, Okumura H, Nakase H, Kimura S. Effect of procaterol histamine-induced pulmonary edema in conscious guinea-pig. The Clinical Report 1990; 24(4)449
   Google Scholar
• Fujimura M, Sakamoto K, Nishi K, Saito M, Miyake Y, Matsuda T. Inhibitory effect of inhaled procaterol on anaphylactic bronchoconstriction and thromboxane A2 production in guinea-pigs. Clin Exp Allergy 1991; 21: 189
   PubMed Web of Science ®Google Scholar
• Ito K. Effect of procaterol on cutaneous reactions. Clin Res 1980; 14(11)3549
   Google Scholar
• Sasaki S, Hotonaga M, Taniguchi K. Anti-allegic effect of procaterol—inhibitory effect on intracutaneous reaction. J New Remedies Clin 1983; 32: 90
   Google Scholar
• Adachi M, Okada T, Kobayashi H, Maruyama S, Sato H, Nishikata H, Takahashi T. A comparison of the protective effect of procaterol aerosol and procaterol tablet on bronchoconstriction induced by methacholine inhalation. Curr Therapeu Res 1986; 40(3)26
   Web of Science ®Google Scholar
• Sakurai S, Ishigaki M, Okada T, Mukousaka Y, Toga H, Nakamura M, Takase K, Magasaka Y. Effects of inhaled β2-stimulant (procaterol) on preventing acetylcholine induced airway constriction and its duration evaluated by repeated inhalation of provocative concentration of acetylcholine. Respir Res 1990; 9(5)587
   Google Scholar
• Ito K, Kono O. Protective effect of procaterol on asthmatic reactions to antigen challenge. J New Remedies Clin 1978; 27: 2127
   Google Scholar
• Nakazawa T, Kanatani K, Kobayashi S. Effect of procaterol on late asthmatic responses in humans. Clin Med 1979; 21: 29
   Google Scholar
• Likura Y, Nagakura T, Walsh G M, Akimoto K, Kishida M, Kondou T, Odajima Y, Okuma M, Akazawa A, Yukishita T. Role of chemical mediators after antigen and exercise challenge in children with asthma. J Allergy Clin Immunol 1988; 81: 1050
   PubMed Web of Science ®Google Scholar
• Asasaka T, Nakayama Y, Hirai M. Prophylactic effect of procaterol on EIB in children with bronchial asthma. J Pediatr Pract 1981; 44(2)239
   Google Scholar
• Nishima S, Fujino T, Mikawa H. Effect of procaterol aerosol on bronchial asthma in children, exercise test in double blind trial. J Pediatr Pract 1985; 48(9)1664
   Google Scholar
• Eichenhorn M S, Beauchamp R K, Harper P A, Ward J C. An assessment of three portable peak flow meters. Chest 1982; 82: 306
   PubMed Web of Science ®Google Scholar
• Darden M D, Sly R M. Evaluation of HealthScan Assess peak flow meters. Ann Allergy 1985; 54: 486
   PubMedGoogle Scholar
• Pedersen S. Aerosol treatment of bronchoconstriction in children, with or without a tube spacer. N Engl J Med 1983; 308: 1328
   PubMed Web of Science ®Google Scholar
• Kim C S, Eldridge M A, Sackner M A. Oropharyngeal deposition and delivery aspects of metereddose inhaler aerosols. Am Rev Respir Dis 1987; 135: 157
   PubMed Web of Science ®Google Scholar
• Makino S, Kobayashi S, Miyamoto T, Nobuta T, Takahashi S, Kabe J, Nakashima S. The standard procedure of provocation test in bronchial asthma and hypersensitivity pneumonitis. Jpn J Allergol 1982; 31: 1074
   PubMedGoogle Scholar
• Church M K, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987; 90: 421
   PubMed Web of Science ®Google Scholar
• Agarwal M K, Gaur S N, Chaudhry S. Effect of prior medication on intradermal test response in patients with respiratory allergies. J Asthma 1988; 25(5)275
   PubMed Web of Science ®Google Scholar
• Mita H, Shida T. Anti-allergic activity of formoterol, a new beta-adrenoceptor stimulant, and salbutamol in human leukocytes and human lung tissue. Allergy 1983; 38: 547
   PubMed Web of Science ®Google Scholar
• Morr H. Anti-allergic effect of beta-2 agonists and cholinoceptor antagonists in vitro. Eur J Respir Dis 1983; 64: 40
   Google Scholar
• Minori N, Taira N. Assessment of the selectivity of OPC-2009 (procaterol), a new β2-adrenoceptor stimulant, by the use of the blood-perfused trachea in site and of the isolated blood-perfused papillary muscle of the dog. Br J Pharmacol 1987; 61: 9
   Google Scholar
• Mitsuhashi M, Kimura T, Tateno K, Morikawa A, Kuroume T. Effect of inhaled procaterol hydrochloride in children with bronchial asthma, with particular reference to duration of effect. J Asthma 1985; 22: 203
   PubMed Web of Science ®Google Scholar
• Arai Y, Nitta K, Shida T. Evaluation of procaterol aerosol as an aerosolized β2-adrenergic bronchodilator in conscious guinea pigs. Jpn J Allergy 1985; 34: 999
   PubMedGoogle Scholar
• Nishima S, Koizumi S, Ohta A, Mikawa H, Okada J. Duration of the antiasthmatic effect of procaterol determined from pulmonary functional responses. Diag Treat 1981; 69: 166
   Google Scholar